[vc_row type=”in_container” full_screen_row_position=”middle” scene_position=”center” text_color=”dark” text_align=”left” top_padding=”5%” overlay_strength=”0.3″][vc_column column_padding=”no-extra-padding” column_padding_position=”all” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_shadow=”none” width=”1/2″ tablet_text_alignment=”default” phone_text_alignment=”default” column_border_width=”none” column_border_style=”solid”][vc_column_text css=”.vc_custom_1501180333626{margin-bottom: 40px !important;}”]

Current Portfolio Companies

[/vc_column_text][vc_custom_heading text=”$40 million invested in eight companies.” font_container=”tag:h3|font_size:24|text_align:left|line_height:38px” google_fonts=”font_family:Roboto%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C500%2C500italic%2C700%2C700italic%2C900%2C900italic|font_style:400%20regular%3A400%3Anormal”][/vc_column][vc_column column_padding=”no-extra-padding” column_padding_position=”all” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_shadow=”none” width=”1/2″ tablet_text_alignment=”default” phone_text_alignment=”default” column_border_width=”none” column_border_style=”solid”][/vc_column][/vc_row][vc_row type=”in_container” full_screen_row_position=”middle” bg_color=”#ffffff” scene_position=”center” text_color=”dark” text_align=”left” overlay_strength=”0.3″][vc_column column_padding=”padding-1-percent” column_padding_position=”left-right” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_shadow=”none” width=”1/1″ tablet_text_alignment=”default” phone_text_alignment=”default” column_border_width=”none” column_border_style=”solid”][vc_row_inner column_margin=”default” text_align=”left”][vc_column_inner column_padding=”padding-1-percent” column_padding_position=”all” background_color_opacity=”1″ width=”1/4″ column_border_width=”none” column_border_style=”solid”]

Encore Vision

Ophthalmology company focused on a novel treatment in presbyopia

[/vc_column_inner][vc_column_inner column_padding=”padding-1-percent” column_padding_position=”all” background_color_opacity=”1″ width=”1/4″ column_border_width=”none” column_border_style=”solid”]

Lung Therapeutics, Inc.

Pulmonology company focused on Fibrosis

[/vc_column_inner][vc_column_inner column_padding=”padding-1-percent” column_padding_position=”all” background_color_opacity=”1″ width=”1/4″ column_border_width=”none” column_border_style=”solid”]

Cognition Therapeutics, Inc.

Neurosciences company focused on Alzheimer’s

[/vc_column_inner][vc_column_inner column_padding=”padding-1-percent” column_padding_position=”all” background_color_opacity=”1″ width=”1/4″ column_border_width=”none” column_border_style=”solid”]

Actuate Therapeutics, Inc.

Oncology company focused on drug and radiation resistance

[/vc_column_inner][/vc_row_inner][vc_row_inner column_margin=”default” text_align=”left”][vc_column_inner column_padding=”padding-1-percent” column_padding_position=”all” background_color_opacity=”1″ width=”1/4″ column_border_width=”none” column_border_style=”solid”]

Azitra, Inc.

Microbiome company focused on eczema and dermatology

[/vc_column_inner][vc_column_inner column_padding=”padding-1-percent” column_padding_position=”all” background_color_opacity=”1″ width=”1/4″ column_border_width=”none” column_border_style=”solid”]

410 Medical, Inc.

Medtech company focused on fluids and trauma

[/vc_column_inner][vc_column_inner column_padding=”padding-1-percent” column_padding_position=”all” background_color_opacity=”1″ width=”1/4″ column_border_width=”none” column_border_style=”solid”]

Abilitech Medical, Inc.

Medtech company focused on orphan diseases

[/vc_column_inner][vc_column_inner column_padding=”padding-1-percent” column_padding_position=”all” background_color_opacity=”1″ width=”1/4″ column_border_width=”none” column_border_style=”solid”]

Lantern Pharma, Inc.

Biotech company focused on precision medicine and oncology

[/vc_column_inner][/vc_row_inner][/vc_column][/vc_row]